AgenT is a French biotech developing the first blood diagnosis to detect Alzheimer's up to 20 years before the onset of the irreversible symptoms. Only company supported by France Alzheimer, AgenT has combined 10 years of academic research, neuroscience and AI to develop a neural network based on 25 biomarkers specific to Alzheimer's.

AgenT's diagnosis identifies Alzheimer's patients that no other current diagnostic tool can detect.